SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000728889-18-001483
Filing Date
2018-09-06
Accepted
2018-09-06 11:58:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 glycomimeticsinc.htm SC 13G 26465
  Complete submission text file 0000728889-18-001483.txt   28167
Mailing Address 225 LIBERTY STREET NEW YORK NY 10281-1008
Business Address 225 LIBERTY STREET NEW YORK NY 10281-1008 212-323-0200
OppenheimerFunds, Inc. (Filed by) CIK: 0000728889 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87811 | Film No.: 181057057
SIC: 2834 Pharmaceutical Preparations